Promethazine Hci Injection
Product Images NDC 51662-1247

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Promethazine Hci (NDC 51662-1247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (1000500 0641 0928 21 Promethazine)

The text is a label of a medication named Promethazine HC! Injection, with NDC number 0641-0928-21. The medication is in a 1mL vial and is recommended to be administered by Deep IM or IV use. It should be protected from light and stored properly.*

FDA Label Image

Serialized Label On Vial (51662 1247 1 Promethazine HCl Injection Serialized Label On Vial)

FDA Label Image

51662124727 Promethazine Pouch Label

PROMETHAZINE HCI INJECTION, USP 25mg/mL 1mL is a medication for deep intramuscular or intravenous use. Its usual dosage is available in the package insert. It is recommended to keep it covered in the carton to protect it from light. The recommended storage temperature is 20°C-25°C (68°-77°F). The manufacturer’s package insert provides additional information. The medication is manufactured by HF Acquisition Co., LLC, located in Mukilteo, WA. The information includes NDC (51662-1247-2), LOT, EXP, and RXONLY.*

FDA Label Image

51662124734 Promethazine Case Label

PROMETHAZINE HCI INJECTION, USP 25mg/mL 1mL is a prescription drug used for deep intramuscular or intravenous use. It has an NDC code of 51662-1247-3, LOT number of 12345, and an expiration date of 2030-01-01. The usual dosage must be confirmed by checking the package insert. It should be kept protected from light and stored at a controlled room temperature. The manufacturer's package insert should be referred. It is manufactured by HF Acquisition Co., LLC with an original NDC code of 0641-0928-25.*

FDA Label Image

51662124734 Promethazine Rfid Label

FDA Label Image

Boxed Warning (Boxed Warning)

This is a warning that Promethazine hydrochloride injection is not safe for use in children under 2 years of age due to the risk of fatal respiratory depression. It can cause severe chemical irritation and tissue damage, leading to burning, pain, thrombophlebitis, tissue necrosis, and gangrene. Intramuscular injection is preferred over intravenous injection, and subcutaneous injection is not recommended. This text provides important information on administration and warnings for this medication.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.